Financial results - NATURA VET PHARM SRL

Financial Summary - Natura Vet Pharm Srl
Unique identification code: 21929850
Registration number: J40/11522/2007
Nace: 7500
Sales - Ron
218.757
Net Profit - Ron
2.601
Employees
8
Open Account
Company Natura Vet Pharm Srl with Fiscal Code 21929850 recorded a turnover of 2024 of 218.757, with a net profit of 2.601 and having an average number of employees of 8. The company operates in the field of Activităţi veterinare having the NACE code 7500.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Natura Vet Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 224.784 216.092 257.482 280.205 293.262 291.521 340.923 346.932 309.423 218.757
Total Income - EUR 227.723 221.363 263.598 287.702 309.858 298.756 348.807 347.844 309.678 225.902
Total Expenses - EUR 221.301 212.411 239.692 278.547 268.404 283.974 312.256 295.425 293.514 222.463
Gross Profit/Loss - EUR 6.422 8.953 23.906 9.155 41.454 14.782 36.551 52.419 16.165 3.439
Net Profit/Loss - EUR 5.633 7.667 21.273 6.278 38.356 11.794 33.377 48.892 12.988 2.601
Employees 4 4 5 6 6 6 10 10 10 8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -28.9%, from 309.423 euro in the year 2023, to 218.757 euro in 2024. The Net Profit decreased by -10.314 euro, from 12.988 euro in 2023, to 2.601 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Natura Vet Pharm Srl

Rating financiar

Financial Rating -
NATURA VET PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Natura Vet Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Natura Vet Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Natura Vet Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Natura Vet Pharm Srl - CUI 21929850

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 9.777 3.834 5.796 7.833 21.286 21.962 42.228 48.272 36.559 22.608
Current Assets 198.791 210.651 232.836 225.175 248.922 202.312 216.243 222.619 205.417 162.695
Inventories 192.754 206.608 229.865 216.180 236.067 178.320 195.087 201.195 184.283 152.155
Receivables 5.596 3.751 1.831 7.572 12.045 21.475 18.562 19.717 20.625 9.941
Cash 440 292 1.140 1.424 810 2.516 2.595 1.707 508 598
Shareholders Funds 33.861 41.182 61.758 66.903 104.169 113.989 144.838 147.220 139.627 117.269
Social Capital 229 227 223 219 421 413 404 406 404 402
Debts 174.708 173.303 176.874 166.106 168.144 110.285 113.632 123.671 102.349 68.033
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7500 - 7500"
CAEN Financial Year 7500
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 162.695 euro in 2024 which includes Inventories of 152.155 euro, Receivables of 9.941 euro and cash availability of 598 euro.
The company's Equity was valued at 117.269 euro, while total Liabilities amounted to 68.033 euro. Equity decreased by -21.578 euro, from 139.627 euro in 2023, to 117.269 in 2024.

Risk Reports Prices

Reviews - Natura Vet Pharm Srl

Comments - Natura Vet Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.